Travere Therapeutics (TVTX) Revenue Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 54.05% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 60.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.29% |
| Dec 31, 2025 | -140.95% |
| Sep 30, 2025 | 12.52% |
| Jun 30, 2025 | 58.70% |
| Mar 31, 2025 | 51.70% |
| Dec 31, 2024 | 35.22% |
| Sep 30, 2024 | 4.57% |
| Jun 30, 2024 | -0.31% |
| Mar 31, 2024 | -4.44% |
| Dec 31, 2023 | -4.03% |
| Sep 30, 2023 | -10.15% |
| Jun 30, 2023 | -12.72% |
| Mar 31, 2023 | -13.53% |
| Dec 31, 2022 | -14.35% |
| Sep 30, 2022 | -14.15% |
| Jun 30, 2022 | -13.80% |
| Mar 31, 2022 | -16.05% |
| Dec 31, 2021 | -77.74% |
| Sep 30, 2021 | 10.55% |
| Jun 30, 2021 | 9.73% |
| Mar 31, 2021 | 7.25% |
| Dec 31, 2020 | 6.52% |
| Sep 30, 2020 | 8.23% |
| Jun 30, 2020 | 7.67% |
| Mar 31, 2020 | 12.42% |
| Dec 31, 2019 | 7.74% |
| Sep 30, 2019 | 9.34% |
| Jun 30, 2019 | 10.31% |
| Mar 31, 2019 | 10.90% |
| Dec 31, 2018 | 12.86% |
| Sep 30, 2018 | 13.28% |
| Jun 30, 2018 | 19.76% |
| Mar 31, 2018 | 30.30% |
| Dec 31, 2017 | 44.14% |
| Sep 30, 2017 | 69.06% |
| Jun 30, 2017 | 89.06% |
| Mar 31, 2017 | 962.87% |